Asociación Española de Gastroenterologia (Spanish Gastroenterology Association) Gastroesophageal Reflux Disease guideline - prospective study - Prospect
Study identifier:NIS-GES-DUM-2007/3
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Symptomatic assessment and therapeutic outcomes in typical GERD patients following a new CP guideline in the clinical practice
Medical condition
GERD
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
300
Study type
Observational
Age
17 Years +
Date
Study Start Date: 01 Dec 2007
Primary Completion Date: 01 Jan 2009
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Feb 2009 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| GERD patients Patients with typical GERD symptoms | - |
Contacts
Investigators
Principal Investigator
Javier Zapardiel
AZ SPAIN
